These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22926302)

  • 1. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate outcomes and predictors of efficacy in the radiofrequency ablation of 100 pathologically proven renal cell carcinomas.
    McClure TD; Chow DS; Tan N; Sayre JA; Pantuck AJ; Raman SS
    J Vasc Interv Radiol; 2014 Nov; 25(11):1682-8; quiz 1689. PubMed ID: 25081202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bipolar versus multipolar radiofrequency (RF) ablation for the treatment of renal cell carcinoma: differences in technical and clinical parameters.
    Sommer CM; Lemm G; Hohenstein E; Stampfl U; Bellemann N; Teber D; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Int J Hyperthermia; 2013; 29(1):21-9. PubMed ID: 23311376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous radiofrequency ablation of sporadic Bosniak III or IV lesions: treatment techniques and short-term outcomes.
    Park JJ; Park BK; Park SY; Kim CK
    J Vasc Interv Radiol; 2015 Jan; 26(1):46-54. PubMed ID: 25446421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
    Dai Y; Covarrubias D; Uppot R; Arellano RS
    J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
    Kim HJ; Park BK; Park JJ; Kim CK
    Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
    Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
    J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
    Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
    AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
    Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
    BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors.
    Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
    Radiology; 2003 Feb; 226(2):417-24. PubMed ID: 12563135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency Ablation of T1a Renal Cell Carcinomas within Renal Transplant Allografts: Oncologic Outcomes and Graft Viability.
    Cool DW; Kachura JR
    J Vasc Interv Radiol; 2017 Dec; 28(12):1658-1663. PubMed ID: 28916346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease.
    Wehrenberg-Klee E; Clark TW; Malkowicz SB; Soulen MC; Wein AJ; Mondschein JI; Van Arsdalen K; Guzzo TJ; Stavropoulos SW
    J Vasc Interv Radiol; 2012 Jan; 23(1):41-5. PubMed ID: 22019179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Image-Guided Thermal Ablation for Multifocal Renal Cell Carcinoma: 10-Year Experience at a Single Center.
    Zhou W; Uppot RN; Feldman AS; Arellano RS
    AJR Am J Roentgenol; 2017 Oct; 209(4):733-739. PubMed ID: 28678572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placement of marker coils at biopsy: usefulness in the localization of poorly visualized renal neoplasms for subsequent CT-guided radiofrequency ablation.
    Pietryga JA; Beland MD; Dupuy DE; Mayo-Smith WW
    Radiology; 2012 May; 263(2):555-61. PubMed ID: 22403171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-Guided Thermal Ablation for Non-resectable Recurrence of Renal Cell Cancer Following Nephrectomy: Clinical Experience with Eleven Patients.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1743-1750. PubMed ID: 29721615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
    Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
    Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
    Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
    World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.